BRAINAURORA-B (06681) Schedules 31 Mar 2026 Board Meeting to Approve FY 2025 Results

Bulletin Express
Mar 19

BrainAurora Medical Technology Limited (BRAINAURORA-B, 06681) announced that its board of directors will meet on Tuesday, 31 March 2026. The agenda includes reviewing and approving the Group’s audited annual results for the financial year ended 31 December 2025, along with authorising their publication.

The current board comprises one executive director (Chairman Tan Zheng), three non-executive directors (Li Sirui, Li Mingqiu and Deng Feng) and three independent non-executive directors (Lam Yiu Por, Dr. Duan Tao and Tu Lei).

The company is incorporated in the Cayman Islands and listed on the Main Board of the Stock Exchange of Hong Kong. All information above is extracted directly from the official company announcement dated 19 March 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10